Edgewise announces completion of EDG-7500 CIRRUS-HCM phase 2 parts B & C and favourable interim safety results from the ongoing part D study in hypertrophic cardiomyopathy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback